SICKLE CELL DISEASE UPDATE: NEW TREATMENTS
Sickle-cell disease is the most common genetic blood disorder, causing blockage of the circulation and resulting painful vaso-occlusive episodes, acute chest syndrome, stroke, chronic anemia, and multiorgan failure, with increased mortality. Three novel medications have been approved in the past fiv...
Saved in:
| Main Author: | Utku Aygüneş |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Hematology, Transfusion and Cell Therapy |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2531137924029328 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
NEW THERAPEUTIC OPTIONS FOR THE TREATMENT OF SICKLE CELL DISEASE
by: Alessandro Matte, et al.
Published: (2019-01-01) -
PATHOPHISIOLOGY OF SICKLE CELL DISEASE AND NEW DRUGS FOR THE TREATMENT
by: Lucia De Franceschi
Published: (2009-12-01) -
Beyond the Definitions of the Phenotypic Complications of Sickle Cell Disease: An Update on Management
by: Samir K. Ballas, et al.
Published: (2012-01-01) -
Hydroxyurea Treatment for Sickle Cell Disease
by: Martin H. Steinberg
Published: (2002-01-01) -
Erratum to “Beyond the Definitions of the Phenotypic Complications of Sickle Cell Disease: An Update on Management”
by: Samir K. Ballas, et al.
Published: (2013-01-01)